近年来，中国医疗机构床位规模保持增势，每千人床位数已突破7张，远超欧美发达国家。与之相对 应的是公立医院住院率居高不下，上级医院虹吸病人而医疗"强基"缺少需求侧支撑。在此背景下，今 年国家卫健委将以"强基、稳二、控三"为原则，进一步调控三级医院规模和发展速度。 1月5日至6日，全国卫生健康工作会议在北京召开，会议在部署2026年工作时提出，今年全国卫生 健康系统要"倾力推进深化医改政策落实"，推进以公益性为导向的公立医院改革，与此同时，精准实 施医疗卫生强基和康复护理扩容提升工程。 "按照'强基、稳二、控三'原则优化医疗机构功能定位和结构，持续推进医疗卫生强基工程，稳定二级 医院运行并拓展康复护理功能，调控三级医院规模、发展速度，优化结构，全面提升医疗卫生服务公 益性、可及性和能力水平。"会议称。 根据国家卫健委去年12月发布的《2024年我国卫生健康事业发展统计公报》，2024年，公立医院床 位扩张态势有所减缓，但全国床位规模仍整体继续增加，每千人口医疗卫生机构床位数由2023年 2026.01. 06 本文字数：944，阅读时长大约1分钟 作者 | 第一财经 吴斯旻 （注：我们会对线索进行核实。您的隐私将 ...

国家卫健委：以"强基、稳二、控三"为原则优化医疗机构功能定位和结构 近年来，中国医疗机构床位规模保持增势，每千人床位数已突破7张，远超欧美发达国家。与之相对应 的是公立医院住院率居高不下，上级医院虹吸病人而医疗"强基"缺少需求侧支撑。在此背景下，今年国 家卫健委将以"强基、稳二、控三"为原则，进一步调控三级医院规模和发展速度。 1月5日至6日，全国卫生健康工作会议在北京召开，会议在部署2026年工作时提出，今年全国卫生健康 系统要"倾力推进深化医改政策落实"，推进以公益性为导向的公立医院改革，与此同时，精准实施医疗 卫生强基和康复护理扩容提升工程。 "按照'强基、稳二、控三'原则优化医疗机构功能定位和结构，持续推进医疗卫生强基工程，稳定二级 医院运行并拓展康复护理功能，调控三级医院规模、发展速度，优化结构，全面提升医疗卫生服务公益 性、可及性和能力水平。"会议称。 根据国家卫健委去年12月发布的《2024年我国卫生健康事业发展统计公报》，2024年，公立医院床位扩 张态势有所减缓，但全国床位规模仍整体继续增加，每千人口医疗卫生机构床位数由2023年7.23张增加 到2024年7.32张。与此同时，当年，一二三 ...

Core Insights - The Chinese engineering machinery industry is increasingly recognized and accepted by international users, with ongoing improvements in overseas business layouts and a forecasted high export level for the year [1] - The industry is expected to maintain stable growth in key economic indicators and foreign trade by 2025, reflecting a steady operational trend [1] Group 1 - The China International Engineering Machinery, Building Materials Machinery, and Mining Machinery Exhibition (BICES 2025) is set to showcase innovations and advancements in the industry, with a significant increase in exhibitors, particularly in high-end, intelligent, and green supply chains [2] - The total exhibition area is expected to exceed 150,000 square meters, featuring four major themed pavilions and 13 special zones [2] - The BICES 2025 will highlight new products, technologies, and achievements, focusing on high-end, green, and intelligent developments, along with a report on the progress of these innovations [2]

Core Viewpoint - The Chinese liquor industry is undergoing a significant adjustment period, with major companies reporting "growth under pressure" in their financial results for 2024 and Q1 2025, highlighting increased competition and market concentration [1][4]. Industry Overview - The white liquor industry is described as facing intensified competition, with a shift from "incremental competition" to "stock competition," leading to a consensus among leading companies that "value reconstruction" will be the main battleground moving forward [1][4]. - The production capacity of white liquor has decreased from a peak of 13.58 million kiloliters in 2016 to 4.145 million kiloliters in 2024, a decline of over 60% [4]. Company Strategies - Yanghe Distillery views 2024 as a year of adjustment, with major companies like Moutai and Wuliangye emphasizing stability in their growth targets, with Moutai setting a 9% growth target for 2025, down from the previous 15% [4][5]. - Yanghe Distillery has adopted a strategy of "active deceleration and inventory reduction," focusing on long-term stability rather than short-term sales growth [5][10]. Competitive Strength - Yanghe Distillery has built a robust product matrix covering all price ranges, which serves as a strong risk mitigation barrier, allowing the company to adapt to consumer segmentation trends and maintain stable operations amid industry fluctuations [5][10]. - The company is implementing six major initiatives to strengthen its foundation, including brand renewal, product optimization, and strategic market focus [8][9]. Financial Performance and Shareholder Returns - Despite facing challenges in revenue and profit, Yanghe Distillery announced a cash dividend plan of 3.49 billion yuan, with a total cash dividend of 7 billion yuan for 2024, reflecting a commitment to shareholder returns [11][12]. - The company has maintained a consistent dividend policy since its listing in 2009, with cumulative dividends amounting to 56.34 billion yuan, representing 72% of its cumulative net profit since listing [11][12].